Home/Investors/Advent Life Sciences

Advent Life Sciences

Biotech Investor · 6 portfolio companies

Portfolio

6

Focus Areas

13

Top Stage

Pre-clinical

Investment Focus

Oncology Hematology Pulmonary Arterial Hypertension Cardiopulmonary Diseases Cardiovascular Heart Failure Neurodegenerative Diseases Ophthalmology Respiratory Dermatology Neurology Autoimmune Diseases Inflammatory Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Aleta Biotherapeutics	Phase 1	—	Oncology, Hematology
Allinaire Therapeutics	Pre-clinical	—	Pulmonary Arterial Hypertension, Cardiopulmonary Diseases
Relief Cardiovascular	Pre-clinical	—	Cardiovascular, Heart Failure
AviadoBio	Phase 1	—	Neurodegenerative Diseases, Ophthalmology
NeRRe Therapeutics	Phase 2	—	Respiratory, Dermatology
Tridek-One	Pre-clinical	—	Autoimmune Diseases, Inflammatory Diseases

Frequent Co-Investors

LifeArc Ventures1 shared Johnson & Johnson Innovation – JJDC1 shared Bpifrance1 shared F-Prime Capital1 shared New Enterprise Associates (NEA)1 shared Broadview Ventures1 shared Monograph Capital1 shared Good Growth Capital1 shared